Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas
Cancers - Switzerland
doi 10.3390/cancers12040884
Full Text
Open PDFAbstract
Available in full text
Date
April 5, 2020
Authors
Publisher
MDPI AG
Available in full text
April 5, 2020
MDPI AG